Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Bei Zhen

The Deubiquitylating Enzyme USP15 Regulates Homologous Recombination Repair and Cancer Cell Response to PARP Inhibitors

Nature Communications

English

Multidimensional Proteomics Reveals a Role of UHRF2 in the Regulation of Epithelial-Mesenchymal Transition (EMT)

Molecular and Cellular Proteomics

English

Related publications

Loss of NFBD1/MDC1 Disrupts Homologous Recombination Repair and Sensitizes Nasopharyngeal Carcinoma Cells to PARP Inhibitors

Journal of Biomedical Science

Clinical Biochemistry

English

mTOR Inhibitors Suppress Homologous Recombination Repair and Synergize With PARP Inhibitors via Regulating SUV39H1 in BRCA-Proficient Triple-Negative Breast Cancer

Clinical Cancer Research

Cancer Research

Oncology

2015

English

Homologous Repair Deficiencies and Current Insights in Clinical Evaluation of PARP Inhibitors in Prostate Cancer

Memo - Magazine of European Medical Oncology

Oncology

Hematology

2020

English

The Lys63-Deubiquitylating Enzyme BRCC36 Limits DNA Break Processing and Repair

Journal of Biological Chemistry

English

Protein Expression of DNA Damage Repair Proteins Dictates Response to Topoisomerase and PARP Inhibitors in Triple-Negative Breast Cancer

PLoS ONE

Multidisciplinary

2015

English

HER2 Overexpression Renders Human Breast Cancers Sensitive to PARP Inhibition Independently of Any Defect in Homologous Recombination DNA Repair

Cancer Research

Oncology

2012

English

SLFN11 Inhibits Checkpoint Maintenance and Homologous Recombination Repair

English

RAD52 Promotes Transcription-Associated Homologous Recombination Repair

Cancer Discovery

Oncology

2018

English

A BRCA1-interacting lncRNA Regulates Homologous Recombination

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Bei Zhen

The Deubiquitylating Enzyme USP15 Regulates Homologous Recombination Repair and Cancer Cell Response to PARP Inhibitors

Multidimensional Proteomics Reveals a Role of UHRF2 in the Regulation of Epithelial-Mesenchymal Transition (EMT)

Related publications

Loss of NFBD1/MDC1 Disrupts Homologous Recombination Repair and Sensitizes Nasopharyngeal Carcinoma Cells to PARP Inhibitors

mTOR Inhibitors Suppress Homologous Recombination Repair and Synergize With PARP Inhibitors via Regulating SUV39H1 in BRCA-Proficient Triple-Negative Breast Cancer

Homologous Repair Deficiencies and Current Insights in Clinical Evaluation of PARP Inhibitors in Prostate Cancer

The Lys63-Deubiquitylating Enzyme BRCC36 Limits DNA Break Processing and Repair

Protein Expression of DNA Damage Repair Proteins Dictates Response to Topoisomerase and PARP Inhibitors in Triple-Negative Breast Cancer

HER2 Overexpression Renders Human Breast Cancers Sensitive to PARP Inhibition Independently of Any Defect in Homologous Recombination DNA Repair

SLFN11 Inhibits Checkpoint Maintenance and Homologous Recombination Repair

RAD52 Promotes Transcription-Associated Homologous Recombination Repair

A BRCA1-interacting lncRNA Regulates Homologous Recombination